We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
3 hedge funds and large institutions have $62.1K invested in Decoy Therapeutics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.02% more ownership
Funds ownership: 0% → 0.02% (+0.02%)
39% less capital invested
Capital invested by funds: $102K → $62.1K (-$39.8K)
57% less funds holding
Funds holding: 7 → 3 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
3
Holders Change
-4
Holders Change %
-57.14%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$44.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.93K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$661 |
Top Sellers
| 1 |
HKAM
Horizon Kinetics Asset Management
New York
|
-$16.4K |
| 2 |
Renaissance Technologies
New York
|
-$15K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$661 |